NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
56 hedge funds and large institutions have $1.02M invested in Navidea Biopharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
56
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7K | |
| 2 | +$4K | |
| 3 | +$2K | |
| 4 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
+$2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.33K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$180K | |
| 3 | -$141K | |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$55K |
| 5 |
Goldman Sachs
New York
|
-$31K |